Literature DB >> 27018087

EUS-guided fine needle biopsy sampling using a novel fork-tip needle: a case-control study.

Pujan Kandel1, Ghassan Tranesh2, Aziza Nassar2, Russell Bingham1, Massimo Raimondo1, Timothy A Woodward1, Victoria Gomez1, Michael B Wallace1.   

Abstract

BACKGROUND AND AIMS: EUS-guided fine needle biopsy (FNB) sampling and FNA are important methods for obtaining core tissues and cytologic aspirates. To improve the specimen quality for pathologic evaluation, a novel EUS-FNB Shark Core (SC) needle has been designed to acquire core tissue during EUS procedures. We compared the histology yield of EUS-FNB sampling using the SC needle (EUS-FNB-SC) to EUS-FNA in patients who had solid pancreatic and nonpancreatic lesions.
METHODS: This was a retrospective case-control study design. Between July 2012 and July 2015 all patients who had EUS-FNB-SC and EUS-FNA were reviewed through a hospital EUS database. Consecutive samples from EUS-FNB-SCs were matched in a 1:3 ratio by lesion site (eg, pancreatic head) and needle gauge (ie, 19 gauge, 22 gauge, 25 gauge) to recent random samples of EUS-FNA. The procedures were performed with rapid onsite evaluation. For study purposes specimen slides were evaluated by 2 cytopathologists for histologic yield using a standard scoring system (0 = no material, 1-2 = cytologic, 3-5 = histologic). The main objectives were to assess the histologic yield of the samples and compare the median number of passes required to obtain core tissue by using EUS-FNB-SC and EUS-FNA needles.
RESULTS: Of the 156 patients included in study, 25% patients (n = 39) were in the EUS-FNB-SC group and 75% (n = 117) in the EUS-FNA group. According to standard scoring criteria for histology, the median histology score for EUS-FNA was 2 (sufficient for cytology but not histology) and for EUS-FNB-SC was 4 (sufficient for adequate histology). Ninety-five percent of the specimens obtained from the EUS-FNB-SC group were of sufficient size for histologic screening, compared with 59% from the EUS-FNA group (P = .01). The median number of passes required to achieve a sample was significantly lower in the EUS-FNB-SC group compared with the EUS-FNA group (2 passes vs 4 passes, P = .001). There was significant difference in the median number of passes to all lesion sites and needle gauges.
CONCLUSIONS: The histology yield was significantly higher using the EUS-FNB-SC needle compared with the EUS-FNA needle. Additionally, fewer passes were required to obtain histology cores when using EUS-FNB-SC.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27018087     DOI: 10.1016/j.gie.2016.03.1405

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  34 in total

1.  Diagnostic yield of small histological cores obtained with a new EUS-guided fine needle biopsy system.

Authors:  Takuya Ishikawa; Rachid Mohamed; Steven J Heitman; Christian Turbide; Puja R Kumar; Hidemi Goto; Yoshiki Hirooka; Paul J Belletrutti
Journal:  Surg Endosc       Date:  2017-05-10       Impact factor: 4.584

2.  Histologic retrieval rate of a newly designed side-bevelled 20G needle for EUS-guided tissue acquisition of solid pancreatic lesions.

Authors:  Elia Armellini; Erminia Manfrin; Elena Trisolini; Silvano Andorno; Marco Ballarè; Laura Bernardoni; Renzo Luciano Boldorini; Armando Gabbrielli; Luca Frulloni; Alberto Larghi; Pietro Occhipinti; Aldo Scarpa; Stefano Francesco Crinò
Journal:  United European Gastroenterol J       Date:  2018-09-30       Impact factor: 4.623

3.  Prospective histological evaluation of a 20G core trap with a forward-cutting bevel needle for EUS-FNA of pancreatic lesions.

Authors:  Nobu Nishioka; Takeshi Ogura; Yoshitaka Kurisu; Miyuki Imanishi; Saori Onda; Wataru Takagi; Tatsushi Sano; Atsushi Okuda; Akira Miyano; Mio Amano; Kazuhide Higuchi
Journal:  Surg Endosc       Date:  2018-03-30       Impact factor: 4.584

Review 4.  Endoscopic ultrasound-guided techniques for diagnosing pancreatic mass lesions: Can we do better?

Authors:  Andrew C Storm; Linda S Lee
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

5.  Prospective evaluation of EUS-guided fine needle biopsy in pancreatic mass lesions.

Authors:  M H Larsen; C W Fristrup; S Detlefsen; M B Mortensen
Journal:  Endosc Int Open       Date:  2018-02-07

6.  Metastatic prostatic stromal sarcoma: A challenging diagnosis on fine-needle aspiration with broad differential diagnosis.

Authors:  Muhammad Siddique Khurram; Ghassan Tranesh; Ramen Sakhi; Ameer Hamza; Warda Ibrar; Roohi Bano
Journal:  Cytojournal       Date:  2017-06-20       Impact factor: 2.091

7.  An Unusual Case of Pancreatic Metastasis from Squamous Cell Carcinoma of the Lung Diagnosed by EUS-Guided Fine Needle Biopsy.

Authors:  Takuya Ishikawa; Yoshiki Hirooka; Carolin J Teman; Hidemi Goto; Paul J Belletrutti
Journal:  Case Rep Gastrointest Med       Date:  2017-05-17

Review 8.  A meta-analysis of endoscopic ultrasound-fine-needle aspiration compared to endoscopic ultrasound-fine-needle biopsy: diagnostic yield and the value of onsite cytopathological assessment.

Authors:  Muhammad Ali Khan; Ian S Grimm; Bilal Ali; Richard Nollan; Claudio Tombazzi; Mohammad Kashif Ismail; Todd H Baron
Journal:  Endosc Int Open       Date:  2017-05

9.  Autoimmune Pancreatitis Diagnosed with Core Biopsy Obtained from a Novel Fork-Tip EUS Needle.

Authors:  Tossapol Kerdsirichairat; Sameer D Saini; Priscilla R Chamberlain; Anoop Prabhu
Journal:  ACG Case Rep J       Date:  2017-01-18

10.  A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore) with the 22-gauge needle in patients with solid pancreatic mass lesions.

Authors:  Mariam Naveed; Ali A Siddiqui; Thomas E Kowalski; David E Loren; Ammara Khalid; Ayesha Soomro; Syed M Mazhar; Joseph Yoo; Raza Hasan; Silpa Yalamanchili; Nicholas Tarangelo; Linda J Taylor; Douglas G Adler
Journal:  Endosc Ultrasound       Date:  2018 Jan-Feb       Impact factor: 5.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.